Results 1 to 10 of about 183,267 (359)
The prevalence of clinically relevant delayed intracranial hemorrhage in head trauma patients treated with oral anticoagulants is very low: a retrospective cohort register study [PDF]
Scandinavian Journal of Trauma, Resuscitation and Emergency MedicineBackground Current guidelines from Scandinavian Neuro Committee mandate a 24-hour observation for head trauma patients on anticoagulants, even with normal initial head CT scans, as a means not to miss delayed intracranial hemorrhages. This study aimed to
Lars André +5 more
doaj +2 more sources
Oral myiasis in brain hemorrhage
Journal of Indian Academy of Oral Medicine and Radiology, 2018 Myiasis is a rare condition which arises from the invasion of body tissues or cavities of living animals or humans by maggots or larvae of certain species of flies. Oral myiasis is seen especially in individuals with neurologic deficit, secondary to oral
Ekta Parmar +3 more
doaj +2 more sources
Risk of intraocular hemorrhage with new oral anticoagulants [PDF]
Eye, 2016 PurposeTo assess the risk of intraocular hemorrhage with warfarin and new oral anticoagulants (NOACs).MethodsWe ascertained all reported cases of intraocular hemorrhage (vitreous, choroidal, or retinal) with warfarin and NOACs (including dabigatran, rivaroxaban, apixaban) from the World Health Organizations's Vigibase database from 1968-2015. We used a
G, Talany, M, Guo, M, Etminan
openaire +3 more sources
Intracranial hemorrhage in the era of the “direct” oral anticoagulants [PDF]
Romanian Journal of Neurology, 2019 Intracranial hemorrhage (ICH) is the most severe complication in patients treated with oral anticoagulants (OACs). Duration of anticoagulant therapy and poor anticoagulation control are important factors for hemorrhagic risk.
Ileana Raluca Nistor, Leonida Gherasim
doaj +2 more sources
Management of intractable oronasal bleeding using Sengstaken-Blakemore tubes in patients with facial trauma: a case series and technical notes [PDF]
Clinical and Experimental Emergency Medicine, 2021 Objective Intractable massive oronasal bleeding can become a life-threatening condition. The success rate of conventional bleeding control methods other than transarterial embolization (TAE) is not expected to be high.
Gi Woon Kim +5 more
doaj +1 more source
Frontiers in Oncology, 2022 ObjectiveWe reported the long-term outcomes of transcatheter chemoembolization (TACE) for patients with late-stage or recurrent oral carcinoma.MethodsThis retrospective study enrolled 18 patients with late-stage or recurrent oral carcinoma between ...
Yonghua Bi +7 more
doaj +1 more source
Frontiers in Pharmacology, 2023 Background: The benefits and risks of starting anticoagulation therapy, such as direct oral anticoagulations (DOACs) or warfarin, in atrial fibrillation (AF) patients with a history of intracranial hemorrhage (ICH) remain controversial.
Qiang Zhou +6 more
doaj +1 more source
Anatolian Journal of Cardiology, 2022 Background: The meta-analysis of randomized controlled trials has illustrated that the efficacy of low-dose non-vitamin K antagonist oral anticoagulants is inferior compared with standard-dose non-vitamin K antagonist oral anticoagulants, though they are
Zei Li +6 more
doaj +1 more source
Management of Oral Anti-Thrombotic Agents Associated Intracerebral Hemorrhage [PDF]
Journal of Neurocritical Care, 2016 Oral anti-thrombotic agents including anti-coagulants or anti-platelet agents are widely used to prevent cerebral infarction in patients with certain risk factors for ischemic stroke. Oral anti-coagulants, particularly warfarin, have long been used after
Yoonkyung Chang +2 more
doaj +1 more source
Non-vitamin K oral anticoagulants (NOACs) in patients with stroke and atrial fibrillation [PDF]
Arhiv za farmaciju, 2020 Patients with atrial fibrillation who had a previous transient ischemic attack or ischemic stroke had a significantly high risk of stroke recurrence and the introduction of oral anticoagulants should be mandatory.
Jovanović Dejana R.
doaj +1 more source